TY - JOUR
AU - D. Bornand
AU - D. Reinau
AU - S. Jick
AU - C. Meier
AD - Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Spitalstrasse 26, 4031, Switzerland.
Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.
School of Public Health, Boston University, Lexington, MA, USA.
Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Spitalstrasse 26, 4031, Switzerland. christoph.meier@usb.ch.
Hospital Pharmacy, University Hospital Basel, Basel, Switzerland. christoph.meier@usb.ch.
Boston Collaborative Drug Surveillance Program, Lexington, MA, USA. christoph.meier@usb.ch.
AN - 35044637
BT - Drug Saf
DO - 10.1007/s40264-021-01140-5
DP - NLM
ET - 2022/01/20
LA - eng
N1 - 1179-1942
Bornand, Delia
Reinau, Daphne
Jick, Susan S
Meier, Christoph R
Orcid: 0000-0002-7120-6378
Journal Article
New Zealand
Drug Saf. 2022 Jan 19. doi: 10.1007/s40264-021-01140-5.
PY - 2022
SN - 0114-5916
T2 - Drug Saf
TI - β-Blockers and the Risk of Depression: A Matched Case-Control Study
ER -